Maxcyte, Inc.: Form 8-K, filed Jan 24, 2022
Filed with the SEC on Jan 24, 2022 and accepted by EDGAR at Jan 24, 2022, 17:05 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-22-006977. Last ingested by Listed: Nov 2, 2026, 10:20 ET. Listed shows no prices and gives no investment advice.